To be sure, the Straits Times Index (STI) constituents will always hold a dear spot in most Singaporeans’ portfolios, thanks to steady dividend yields. No doubt the STI stocks have seen a rather good performance this year, but using Bloomberg data as of Dec 12, The Edge Singapore notes that the largest gainers are outside of the STI, with the Addvalue Technologies, iX Biopharma and CNMC Goldmine taking the top three highest returns spots with returns from 341% to 455%. The list of stocks do not include companies listed this year. MetaOptics, which was listed only in September, has gained 480% since then.
Singapore’s capital market participants will remember 2025 with some fond-ness. While the year started rather calmly, news, chatter and noise caused waves in the markets as the year went by. Trade tensions and tariffs aside, what really caused market sentiment to rise this year were efforts made by the Monetary Authority of Singapore (MAS).
Between the “Value Unlock” programme, Equity Market Development Programme (EQDP), SGX-Nasdaq dual-listing partnership, as well as several changes to the Singapore Exchange (SGX) regulations, market sentiment has been positive. Instead of the usual banks, a broader swathe of counters enjoyed handsome gains, as more investors act on the long-held view that the overall market is undervalued.
